Every parliamentary written question tabled by Derek Twigg this session, with the full answer and department. Back to the MP page.
Showing 81–86 of 86 · this parliament
How many and what proportion patients who attended A&E with a respiratory condition and were admitted to a hospital ward were subsequently readmitted with a respiratory condition at a later date at each acute hospital trust since 2019.
A table showing the information requested is attached.
Which organisation is responsible for procuring radiotherapy machines.
Responsibility for purchasing radiotherapy treatment machines sits with local systems. The Government committed £70 million for new machines in last year’s Budget, to ensure that the most advanced treatment is available to patients who need it.
If she will make an assessment of the potential merits of classifying clinical engineers as healthcare professionals under the Health and Care Worker Visa.
The Home Office keeps all its immigration visa routes under regular review, which includes consulting the Department of Health and Social Care on which occupations should be eligible for the Health and Care Visa.
What the (a) number of each rank in post of and (b) requirement for each rank of medical service personnel was on 1 April 2024.
I am withholding the information as its disclosure would, or would be likely to prejudice the capability, effectiveness or security of the Armed Forces.
How many people in Widnes and Halewood constituency were being treated for lung cancer as of 1 October 2024.
We do not collect data on the number of people treated for lung cancer by constituency. However, we do have the total number of people being treated for lung cancer across trusts throughout the country. The number of people who received either a first or subsequent treatment for lung cancer in September 2024 was 4,676.
What funding his Department has provided for child brain tumour research in each year since 2015.
The Department invests £1.5 billion per year in health research through the National Institute for Health and Care Research (NIHR), and NIHR research expenditure for all cancers was £121.8 million in 2022/23. Cancer is a major area of NIHR spend, reflecting its high priority.For research specifically on child brain tumours, the NIHR has made three direct awards since 2015 with a total value of approximately £650,000. The following table shows the NIHR’s committed spend on research into child brain tumours in each year since 2015/16, and the total award budget:Financial yearTotal2015/16£02016/17£02017/18£54,3052018/19£59,1102019/20£64,0582020/21£57,6912021/22£02022/23£48,8012023/24£179,149Total award budget£649,614Between 2018/19 and 2022/23, the NIHR directly invested £11.3 million in research projects and programmes focused on brain tumors across 15 awards. Additionally, wider NIHR investment in research infrastructure, supporting the facilities, services, and the research workforce, supported the delivery of 227 brain cancer research studies over this period, enabling an estimated 8,500 people to participate in research at estimated cost of £31.5 million. This NIHR infrastructure-supported research included a significant number of studies involving children and young people, including those delivered by NIHR Great Ormond Street Biomedical Research Centre.In September 2024, the NIHR announced new research funding opportunities for brain cancer research, spanning both adult and paediatric populations. This includes a national NIHR Brain Tumour Research Consortium, to ensure the most promising research opportunities are made available to adult and child patients, and a new funding call to generate high quality evidence in brain tumour care, support, and rehabilitation. Further information on these opportunities is available at the following link:https://www.nihr.ac.uk/news/new-funding-opportunities-novel-brain-tumour-research-launchedThe NIHR continues to encourage and welcome applications for research into any aspect of human health, including childhood cancer. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.